AQR Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,645
| Closed | -$102K | – | 3231 |
|
2024
Q4 | $102K | Sell |
10,645
-313,455
| -97% | -$3.01M | ﹤0.01% | 2761 |
|
2024
Q3 | $927K | Buy |
324,100
+272,359
| +526% | +$779K | ﹤0.01% | 1887 |
|
2024
Q2 | $151K | Buy |
51,741
+40,882
| +376% | +$119K | ﹤0.01% | 2459 |
|
2024
Q1 | $34.6K | Sell |
10,859
-12,781
| -54% | -$40.8K | ﹤0.01% | 2382 |
|
2023
Q4 | $79.4K | Sell |
23,640
-63,343
| -73% | -$213K | ﹤0.01% | 2286 |
|
2023
Q3 | $207K | Sell |
86,983
-61,919
| -42% | -$147K | ﹤0.01% | 2134 |
|
2023
Q2 | $262K | Buy |
148,902
+113,690
| +323% | +$200K | ﹤0.01% | 1990 |
|
2023
Q1 | $108K | Buy |
+35,212
| New | +$108K | ﹤0.01% | 2111 |
|